{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:08:52Z","timestamp":1790615332106,"version":"4.1.0"},"reference-count":125,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["125440785 \u2013 SFB 877"],"award-info":[{"award-number":["125440785 \u2013 SFB 877"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["80750187 \u2013 SFB 841"],"award-info":[{"award-number":["80750187 \u2013 SFB 841"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["A14"],"award-info":[{"award-number":["A14"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.bbamcr.2021.119141","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T08:13:57Z","timestamp":1633335237000},"page":"119141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["ADAM17 orchestrates Interleukin-6, TNF\u03b1 and EGF-R signaling in inflammation and cancer"],"prefix":"10.1016","volume":"1869","author":[{"given":"Neele","family":"Schumacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Rose-John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5996","key":"10.1016\/j.bbamcr.2021.119141_bb0005","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/312724a0","article-title":"Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin","volume":"312","author":"Pennica","year":"1984","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.bbamcr.2021.119141_bb0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0014-5793(86)80306-4","article-title":"Synthesis and maturation of recombinant human tumor necrosis factor in eukaryotic systems","volume":"197","author":"M\u00fcller","year":"1986","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.bbamcr.2021.119141_bb0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0092-8674(88)90486-2","article-title":"A novel form of TNF\/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF","volume":"53","author":"Kriegler","year":"1988","journal-title":"Cell"},{"issue":"4607","key":"10.1016\/j.bbamcr.2021.119141_bb0020","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1126\/science.6602382","article-title":"Structure of a mouse submaxillary messenger RNA encoding epidermal growth factor and seven related proteins","volume":"221","author":"Scott","year":"1983","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bbamcr.2021.119141_bb0025","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0092-8674(87)90194-2","article-title":"Different transforming growth factor-alpha species are derived from a glycosylated and palmitoylated transmembrane precursor","volume":"48","author":"Bringman","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2021.119141_bb0030","first-page":"51","article-title":"Soluble and cell surface receptors for tumor necrosis factor","volume":"35","author":"Wallach","year":"1991","journal-title":"Agents Actions Suppl."},{"issue":"Pt 2","key":"10.1016\/j.bbamcr.2021.119141_bb0035","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/bj3000281","article-title":"Soluble receptors for cytokines and growth factors: generation and biological function","volume":"300","author":"Rose-John","year":"1994","journal-title":"Biochem. J."},{"issue":"6618","key":"10.1016\/j.bbamcr.2021.119141_bb0040","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/385729a0","article-title":"A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells","volume":"385","author":"Black","year":"1997","journal-title":"Nature"},{"issue":"6618","key":"10.1016\/j.bbamcr.2021.119141_bb0045","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/385733a0","article-title":"Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha","volume":"385","author":"Moss","year":"1997","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.bbamcr.2021.119141_bb0050","doi-asserted-by":"crossref","first-page":"10783","DOI":"10.1073\/pnas.90.22.10783","article-title":"The precursor region of a protein active in sperm-egg fusion contains a metalloprotease and a disintegrin domain: structural, functional, and evolutionary implications","volume":"90","author":"Wolfsberg","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.bbamcr.2021.119141_bb0055","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0955-0674(98)80042-2","article-title":"ADAMs: focus on the protease domain","volume":"10","author":"Black","year":"1998","journal-title":"Curr. Opin. Cell Biol."},{"issue":"1","key":"10.1016\/j.bbamcr.2021.119141_bb0060","first-page":"27","article-title":"The importance of shedding of membrane proteins for cytokine biology","volume":"11","author":"Mullberg","year":"2000","journal-title":"Eur. Cytokine Netw."},{"issue":"8","key":"10.1016\/j.bbamcr.2021.119141_bb0065","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.it.2011.05.005","article-title":"ADAM17: a molecular switch to control inflammation and tissue regeneration","volume":"32","author":"Scheller","year":"2011","journal-title":"Trends Immunol."},{"issue":"11 Pt B","key":"10.1016\/j.bbamcr.2021.119141_bb0070","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.bbamcr.2017.07.001","article-title":"The shedding protease ADAM17: physiology and pathophysiology","volume":"1864","author":"Zunke","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"19","key":"10.1016\/j.bbamcr.2021.119141_bb0075","doi-asserted-by":"crossref","first-page":"12135","DOI":"10.1074\/jbc.M114.624072","article-title":"The functional maturation of a disintegrin and metalloproteinase (ADAM) 9, 10, and 17 requires processing at a newly identified proprotein convertase (PC) cleavage site","volume":"290","author":"Wong","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"6065","key":"10.1016\/j.bbamcr.2021.119141_bb0080","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1126\/science.1214400","article-title":"Tumor necrosis factor signaling requires iRhom2 to promote trafficking and activation of TACE","volume":"335","author":"Adrain","year":"2012","journal-title":"Science"},{"issue":"6065","key":"10.1016\/j.bbamcr.2021.119141_bb0085","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1126\/science.1214448","article-title":"iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS","volume":"335","author":"McIlwain","year":"2012","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bbamcr.2021.119141_bb0090","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.celrep.2017.09.074","article-title":"Phosphorylation of iRhom2 controls stimulated proteolytic shedding by the metalloprotease ADAM17\/TACE","volume":"21","author":"Cavadas","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbamcr.2021.119141_bb0095","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.23968","article-title":"Phosphorylation of iRhom2 at the plasma membrane controls mammalian TACE-dependent inflammatory and growth factor signalling","volume":"6","author":"Grieve","year":"2017","journal-title":"Elife"},{"issue":"6","key":"10.1016\/j.bbamcr.2021.119141_bb0100","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1091\/mbc.01-11-0561","article-title":"Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding","volume":"13","author":"Diaz-Rodriguez","year":"2002","journal-title":"Mol. Biol. Cell"},{"issue":"5","key":"10.1016\/j.bbamcr.2021.119141_bb0105","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1074\/jbc.M113.536847","article-title":"Polo-like kinase 2, a novel ADAM17 signaling component, regulates tumor necrosis factor alpha ectodomain shedding","volume":"289","author":"Schwarz","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"19","key":"10.1016\/j.bbamcr.2021.119141_bb0110","doi-asserted-by":"crossref","first-page":"14608","DOI":"10.1074\/jbc.275.19.14608","article-title":"Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme","volume":"275","author":"Reddy","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2021.119141_bb0115","doi-asserted-by":"crossref","unstructured":"J. Schwarz, C. Broder, A. Helmstetter, S. Schmidt, I. Yan, M. Muller, D. Schmidt-Arras, C. Becker-Pauly, F. Koch-Nolte, H.W. Mittrucker, B. Rabe, S. Rose-John, A. Chalaris, Short-term TNFalpha shedding is independent of cytoplasmic phosphorylation or furin cleavage of ADAM17, Biochim. Biophys. Acta 1833(12) (2013) 3355\u20133367.","DOI":"10.1016\/j.bbamcr.2013.10.005"},{"issue":"10","key":"10.1016\/j.bbamcr.2021.119141_bb0120","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.4049\/jimmunol.1701556","article-title":"Structural and functional analyses of the shedding protease ADAM17 in HoxB8-immortalized macrophages and dendritic-like cells","volume":"201","author":"Cabron","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbamcr.2021.119141_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100733","article-title":"Targeted truncation of the ADAM17 cytoplasmic domain in mice results in protein destabilization and a hypomorphic phenotype","author":"Lora","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2021.119141_bb0130","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.35012","article-title":"FRMD8 promotes inflammatory and growth factor signalling by stabilising the iRhom\/ADAM17 sheddase complex","volume":"7","author":"Kunzel","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.bbamcr.2021.119141_bb0135","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.35032","article-title":"iTAP, a novel iRhom interactor, controls TNF secretion by policing the stability of iRhom\/TACE","volume":"7","author":"Oikonomidi","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.bbamcr.2021.119141_bb0140","doi-asserted-by":"crossref","first-page":"11523","DOI":"10.1038\/ncomms11523","article-title":"Phosphatidylserine exposure is required for ADAM17 sheddase function","volume":"7","author":"Sommer","year":"2016","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bbamcr.2021.119141_bb0145","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1042\/BJ20100179","article-title":"Thiol isomerases negatively regulate the cellular shedding activity of ADAM17","volume":"428","author":"Willems","year":"2010","journal-title":"Biochem. J."},{"issue":"15","key":"10.1016\/j.bbamcr.2021.119141_bb0150","doi-asserted-by":"crossref","first-page":"5776","DOI":"10.1021\/ja400340u","article-title":"Membrane-proximal domain of a disintegrin and metalloprotease-17 represents the putative molecular switch of its shedding activity operated by protein-disulfide isomerase","volume":"135","author":"Dusterhoft","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbamcr.2021.119141_bb0155","doi-asserted-by":"crossref","unstructured":"S. Dusterhoft, A. Babendreyer, A.A. Giese, C. Flasshove, A. Ludwig, Status update on iRhom and ADAM17: it's still complicated, Biochim. Biophys. Acta, Mol. Cell Res. 1866(10) (2019) 1567\u20131583.","DOI":"10.1016\/j.bbamcr.2019.06.017"},{"issue":"6","key":"10.1016\/j.bbamcr.2021.119141_bb0160","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nri3834","article-title":"Regulation of tumour necrosis factor signalling: live or let die","volume":"15","author":"Brenner","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.bbamcr.2021.119141_bb0165","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0092-8674(95)90192-2","article-title":"The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80\u00a0kDa tumor necrosis factor receptor","volume":"83","author":"Grell","year":"1995","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bbamcr.2021.119141_bb0170","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/ni.1714","article-title":"Death receptor signal transducers: nodes of coordination in immune signaling networks","volume":"10","author":"Wilson","year":"2009","journal-title":"Nat. Immunol."},{"issue":"5229","key":"10.1016\/j.bbamcr.2021.119141_bb0175","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1126\/science.7544915","article-title":"TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40","volume":"269","author":"Rothe","year":"1995","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bbamcr.2021.119141_bb0180","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","article-title":"TNF biology, pathogenic mechanisms and emerging therapeutic strategies","volume":"12","author":"Kalliolias","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"issue":"4","key":"10.1016\/j.bbamcr.2021.119141_bb0185","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.yexcr.2008.10.011","article-title":"The role of protease activity in ErbB biology","volume":"315","author":"Blobel","year":"2009","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.bbamcr.2021.119141_bb0190","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.febslet.2006.11.074","article-title":"Ectodomain shedding of the EGF-receptor ligand epigen is mediated by ADAM17","volume":"581","author":"Sahin","year":"2007","journal-title":"FEBS Lett."},{"issue":"5","key":"10.1016\/j.bbamcr.2021.119141_bb0195","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1083\/jcb.200307137","article-title":"Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands","volume":"164","author":"Sahin","year":"2004","journal-title":"J. Cell Biol."},{"issue":"6764","key":"10.1016\/j.bbamcr.2021.119141_bb0200","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/47260","article-title":"EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF","volume":"402","author":"Prenzel","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2021.119141_bb0205","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ncomms1232","article-title":"Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17","volume":"2","author":"Maretzky","year":"2011","journal-title":"Nat. Commun."},{"issue":"17","key":"10.1016\/j.bbamcr.2021.119141_bb0210","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1242\/dev.01966","article-title":"Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin","volume":"132","author":"Sternlicht","year":"2005","journal-title":"Development"},{"issue":"8","key":"10.1016\/j.bbamcr.2021.119141_bb0215","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1084\/jem.20092366","article-title":"Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice","volume":"207","author":"Chalaris","year":"2010","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.bbamcr.2021.119141_bb0220","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrm1548","article-title":"ADAMs: key components in EGFR signalling and development","volume":"6","author":"Blobel","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4867","key":"10.1016\/j.bbamcr.2021.119141_bb0225","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.3136546","article-title":"Cloning and expression of the human interleukin-6 (BSF-2\/IFN beta 2) receptor","volume":"241","author":"Yamasaki","year":"1988","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.bbamcr.2021.119141_bb0230","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/0092-8674(90)90411-7","article-title":"Molecular cloning and expression of an IL-6 signal transducer, gp130","volume":"63","author":"Hibi","year":"1990","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bbamcr.2021.119141_bb0235","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.immuni.2019.03.026","article-title":"Targeting interleukin-6 signaling in clinic","volume":"50","author":"Kang","year":"2019","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.bbamcr.2021.119141_bb0240","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/0006-291X(92)92272-Y","article-title":"Protein kinase C activity is rate limiting for shedding of the interleukin-6 receptor","volume":"189","author":"Mullberg","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.bbamcr.2021.119141_bb0245","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/eji.1830230226","article-title":"The soluble interleukin-6 receptor is generated by shedding","volume":"23","author":"Mullberg","year":"1993","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.bbamcr.2021.119141_bb0250","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.4049\/jimmunol.149.6.2021","article-title":"Complex of soluble human IL-6-receptor\/IL-6 up-regulates expression of acute-phase proteins","volume":"149","author":"Mackiewicz","year":"1992","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.bbamcr.2021.119141_bb0255","doi-asserted-by":"crossref","first-page":"a028415","DOI":"10.1101\/cshperspect.a028415","article-title":"Interleukin-6 family cytokines","volume":"10","author":"Rose-John","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"6\u20137","key":"10.1016\/j.bbamcr.2021.119141_bb0260","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ejcb.2010.10.007","article-title":"The soluble interleukin 6 receptor: generation and role in inflammation and cancer","volume":"90","author":"Chalaris","year":"2011","journal-title":"Eur. J. Cell Biol."},{"issue":"23","key":"10.1016\/j.bbamcr.2021.119141_bb0265","doi-asserted-by":"crossref","first-page":"16336","DOI":"10.1074\/jbc.M114.557322","article-title":"A disintegrin and metalloprotease 17 dynamic interaction sequence, the sweet tooth for the human interleukin 6 receptor","volume":"289","author":"Dusterhoft","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"28","key":"10.1016\/j.bbamcr.2021.119141_bb0270","doi-asserted-by":"crossref","first-page":"11433","DOI":"10.1073\/pnas.1302553110","article-title":"iRhom2 controls the substrate selectivity of stimulated ADAM17-dependent ectodomain shedding","volume":"110","author":"Maretzky","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.bbamcr.2021.119141_bb0275","doi-asserted-by":"crossref","first-page":"4956","DOI":"10.1096\/fj.201902649R","article-title":"Substrate-selective protein ectodomain shedding by ADAM17 and iRhom2 depends on their juxtamembrane and transmembrane domains","volume":"34","author":"Tang","year":"2020","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.bbamcr.2021.119141_bb0280","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1042\/CS20180842","article-title":"Rare mutations of ADAM17 from TOFs induce hypertrophy in human embryonic stem cell-derived cardiomyocytes via HB-EGF signaling","volume":"133","author":"Xie","year":"2019","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.bbamcr.2021.119141_bb0285","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.cytogfr.2020.04.003","article-title":"Biological functions and therapeutic opportunities of soluble cytokine receptors","volume":"55","author":"Lokau","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"5392","key":"10.1016\/j.bbamcr.2021.119141_bb0290","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.282.5392.1281","article-title":"An essential role for ectodomain shedding in mammalian development","volume":"282","author":"Peschon","year":"1998","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.bbamcr.2021.119141_bb0295","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.4049\/jimmunol.178.7.4214","article-title":"Non-cell autonomous expression of TNF-alpha-converting enzyme ADAM17 is required for normal lymphocyte development","volume":"178","author":"Li","year":"2007","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.bbamcr.2021.119141_bb0300","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.1210\/en.2008-0775","article-title":"Deficiency of TNFalpha converting enzyme (TACE\/ADAM17) causes a lean, hypermetabolic phenotype in mice","volume":"149","author":"Gelling","year":"2008","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.bbamcr.2021.119141_bb0305","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.4049\/jimmunol.179.5.2686","article-title":"Cutting edge: TNF-alpha-converting enzyme (TACE\/ADAM17) inactivation in mouse myeloid cells prevents lethality from endotoxin shock","volume":"179","author":"Horiuchi","year":"2007","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.bbamcr.2021.119141_bb0310","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ccr.2012.07.024","article-title":"EGF receptor is required for KRAS-induced pancreatic tumorigenesis","volume":"22","author":"Ardito","year":"2012","journal-title":"Cancer Cell"},{"issue":"13","key":"10.1016\/j.bbamcr.2021.119141_bb0315","doi-asserted-by":"crossref","first-page":"e87023","DOI":"10.1172\/jci.insight.87023","article-title":"ADAM17 substrate release in proximal tubule drives kidney fibrosis","volume":"1","author":"Kefaloyianni","year":"2016","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.bbamcr.2021.119141_bb0320","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1160\/TH17-07-0494","article-title":"The ADAM17 metalloproteinase maintains arterial elasticity","volume":"118","author":"Nicolaou","year":"2018","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.bbamcr.2021.119141_bb0325","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1161\/ATVBAHA.116.308682","article-title":"Adam17 deficiency promotes atherosclerosis by enhanced TNFR2 signaling in mice","volume":"37","author":"Nicolaou","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.bbamcr.2021.119141_bb0330","doi-asserted-by":"crossref","first-page":"e9976","DOI":"10.15252\/emmm.201809976","article-title":"ADAM17 selectively activates the IL-6 trans-signaling\/ERK MAPK axis in KRAS-addicted lung cancer","volume":"11","author":"Saad","year":"2019","journal-title":"EMBO Mol Med"},{"issue":"2","key":"10.1016\/j.bbamcr.2021.119141_bb0335","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1165\/rcmb.2020-0214OC","article-title":"ADAM17 deficiency protects against pulmonary emphysema","volume":"64","author":"Saad","year":"2021","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"4","key":"10.1016\/j.bbamcr.2021.119141_bb0340","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/carcin\/bgz123","article-title":"The ADAM17 protease promotes tobacco smoke carcinogen-induced lung tumorigenesis","volume":"41","author":"Saad","year":"2020","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.bbamcr.2021.119141_bb0345","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1084\/jem.20171696","article-title":"ADAM17 is required for EGF-R-induced intestinal tumors via IL-6 trans-signaling","volume":"215","author":"Schmidt","year":"2018","journal-title":"J. Exp. Med."},{"issue":"21","key":"10.1016\/j.bbamcr.2021.119141_bb0350","doi-asserted-by":"crossref","first-page":"7512","DOI":"10.1128\/MCB.22.21.7512-7523.2002","article-title":"Etk\/Bmx as a tumor necrosis factor receptor type 2-specific kinase: role in endothelial cell migration and angiogenesis","volume":"22","author":"Pan","year":"2002","journal-title":"Mol. Cell. Biol."},{"issue":"3","key":"10.1016\/j.bbamcr.2021.119141_bb0355","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1160\/TH16-09-0674","article-title":"Contrasting effects of myeloid and endothelial ADAM17 on atherosclerosis development","volume":"117","author":"van der Vorst","year":"2017","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.bbamcr.2021.119141_bb0360","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.1096\/fj.201801901R","article-title":"Impaired mechanical, heat, and cold nociception in a murine model of genetic TACE\/ADAM17 knockdown","volume":"33","author":"Quarta","year":"2019","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.bbamcr.2021.119141_bb0365","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1136\/gutjnl-2019-320022","article-title":"25 years of anti-TNF treatment for inflammatory bowel disease: lessons from the past and a look to the future","volume":"70","author":"D'Haens","year":"2021","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.bbamcr.2021.119141_bb0370","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nri802","article-title":"Development of anti-TNF therapy for rheumatoid arthritis","volume":"2","author":"Feldmann","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbamcr.2021.119141_bb0375","doi-asserted-by":"crossref","unstructured":"S.K. Maney, D.R. McIlwain, R. Polz, A.A. Pandyra, B. Sundaram, D. Wolff, K. Ohishi, T. Maretzky, M.A. Brooke, A. Evers, A.A. Vasudevan, N. Aghaeepour, J. Scheller, C. Munk, D. Haussinger, T.W. Mak, G.P. Nolan, D.P. Kelsell, C.P. Blobel, K.S. Lang, P.A. Lang, Deletions in the cytoplasmic domain of iRhom1 and iRhom2 promote shedding of the TNF receptor by the protease ADAM17, Sci. Signal. 8(401) (2015) ra109.","DOI":"10.1126\/scisignal.aac5356"},{"issue":"13","key":"10.1016\/j.bbamcr.2021.119141_bb0380","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1096\/fj.99-0913com","article-title":"Liver regeneration induced by a designer human IL-6\/sIL-6R fusion protein reverses severe hepatocellular injury","volume":"14","author":"Galun","year":"2000","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.bbamcr.2021.119141_bb0385","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1053\/gast.2000.20236","article-title":"Combined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration","volume":"119","author":"Peters","year":"2000","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.bbamcr.2021.119141_bb0390","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1515\/hsz-2021-0149","article-title":"The role of ADAM17 during liver damage","volume":"402","author":"Al-Salihi","year":"2021","journal-title":"Biol. Chem."},{"issue":"16","key":"10.1016\/j.bbamcr.2021.119141_bb0395","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1056\/NEJMoa1100721","article-title":"Inflammatory skin and bowel disease linked to ADAM17 deletion","volume":"365","author":"Blaydon","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bbamcr.2021.119141_bb0400","doi-asserted-by":"crossref","first-page":"9552","DOI":"10.1038\/s41598-021-89063-0","article-title":"Functionally confirmed compound heterozygous ADAM17 missense loss-of-function variants cause neonatal inflammatory skin and bowel disease 1","volume":"11","author":"Imoto","year":"2021","journal-title":"Sci. Rep."},{"issue":"18","key":"10.1016\/j.bbamcr.2021.119141_bb0405","doi-asserted-by":"crossref","first-page":"6688","DOI":"10.3390\/ijms21186688","article-title":"Blocking ADAM17 function with a monoclonal antibody improves sepsis survival in a murine model of polymicrobial sepsis","volume":"21","author":"Mishra","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bbamcr.2021.119141_bb0410","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1189\/jlb.3A0515-207R","article-title":"ADAM17 controls IL-6 signaling by cleavage of the murine IL-6Ralpha from the cell surface of leukocytes during inflammatory responses","volume":"99","author":"Yan","year":"2016","journal-title":"J. Leukoc. Biol."},{"issue":"9","key":"10.1016\/j.bbamcr.2021.119141_bb0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184320","article-title":"The role of ADAM17 in the T-cell response against bacterial pathogens","volume":"12","author":"Link","year":"2017","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.bbamcr.2021.119141_bb0420","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1164\/rccm.201512-2368OC","article-title":"Therapeutic targeting of the IL-6 trans-signalling\/mTORC1 axis in pulmonary emphysema","volume":"194","author":"Ruwanpura","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.bbamcr.2021.119141_bb0425","first-page":"928","article-title":"iRHOM2 is a critical pathogenic mediator of inflammatory arthritis","volume":"123","author":"Issuree","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2021.119141_bb0430","first-page":"269","article-title":"In vivo models of rheumatoid arthritis, methods","volume":"1914","author":"Grotsch","year":"2019","journal-title":"Mol. Biol."},{"issue":"3","key":"10.1016\/j.bbamcr.2021.119141_bb0435","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.190003","article-title":"The molecular, cellular and pathophysiological roles of iRhom pseudoproteases","volume":"9","author":"Dulloo","year":"2019","journal-title":"Open Biol."},{"issue":"9","key":"10.1016\/j.bbamcr.2021.119141_bb0440","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1084\/jem.20020165","article-title":"Genetic modifiers of systemic lupus erythematosus in FcgammaRIIB\u2212\/\u2212 mice","volume":"195","author":"Bolland","year":"2002","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.bbamcr.2021.119141_bb0445","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1172\/JCI97650","article-title":"iRhom2 promotes lupus nephritis through TNF-alpha and EGFR signaling","volume":"128","author":"Qing","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.bbamcr.2021.119141_bb0450","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1432-0436.2007.00238.x","article-title":"The epidermal growth factor receptor: from development to tumorigenesis","volume":"75","author":"Sibilia","year":"2007","journal-title":"Differentiation"},{"issue":"1","key":"10.1016\/j.bbamcr.2021.119141_bb0455","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1053\/j.gastro.2017.03.053","article-title":"EGFR in tumor-associated myeloid cells promotes development of colorectal cancer in mice and associates with outcomes of patients","volume":"153","author":"Srivatsa","year":"2017","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.bbamcr.2021.119141_bb0460","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1158\/0008-5472.CAN-15-2388","article-title":"IL6 trans-signaling promotes KRAS-driven lung carcinogenesis","volume":"76","author":"Brooks","year":"2016","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbamcr.2021.119141_bb0465","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-5793(98)01031-X","article-title":"TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3","volume":"435","author":"Amour","year":"1998","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.bbamcr.2021.119141_bb0470","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc.2016.115","article-title":"TIMPs: versatile extracellular regulators in cancer","volume":"17","author":"Jackson","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.bbamcr.2021.119141_bb0475","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/gb-2011-12-11-233","article-title":"Tissue inhibitors of metalloproteinases","volume":"12","author":"Murphy","year":"2011","journal-title":"Genome Biol."},{"issue":"3","key":"10.1016\/j.bbamcr.2021.119141_bb0480","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.celrep.2016.06.027","article-title":"A role for Timp3 in microbiota-driven hepatic steatosis and metabolic dysfunction","volume":"16","author":"Mavilio","year":"2016","journal-title":"Cell Rep."},{"issue":"5564","key":"10.1016\/j.bbamcr.2021.119141_bb0485","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1126\/science.1067100","article-title":"Matrix metalloproteinase inhibitors and cancer: trials and tribulations","volume":"295","author":"Coussens","year":"2002","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.bbamcr.2021.119141_bb0490","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nrc884","article-title":"Strategies for MMP inhibition in cancer: innovations for the post-trial era","volume":"2","author":"Overall","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"6486","key":"10.1016\/j.bbamcr.2021.119141_bb0495","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/370218a0","article-title":"Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing","volume":"370","author":"Mohler","year":"1994","journal-title":"Nature"},{"issue":"6490","key":"10.1016\/j.bbamcr.2021.119141_bb0500","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/370558a0","article-title":"Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor","volume":"370","author":"McGeehan","year":"1994","journal-title":"Nature"},{"issue":"6490","key":"10.1016\/j.bbamcr.2021.119141_bb0505","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/370555a0","article-title":"Processing of tumour necrosis factor-alpha precursor by metalloproteinases","volume":"370","author":"Gearing","year":"1994","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bbamcr.2021.119141_bb0510","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1073\/pnas.95.7.3408","article-title":"Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme","volume":"95","author":"Maskos","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Pt 1","key":"10.1016\/j.bbamcr.2021.119141_bb0515","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1042\/bj3170045","article-title":"Molecular cloning of MADM: a catalytically active mammalian disintegrin-metalloprotease expressed in various cell types","volume":"317","author":"Howard","year":"1996","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.bbamcr.2021.119141_bb0520","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/1386207053258488","article-title":"Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules","volume":"8","author":"Ludwig","year":"2005","journal-title":"Comb. Chem. High Throughput Screen."},{"issue":"4","key":"10.1016\/j.bbamcr.2021.119141_bb0525","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1182\/blood-2002-12-3775","article-title":"The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion","volume":"102","author":"Hundhausen","year":"2003","journal-title":"Blood"},{"issue":"48","key":"10.1016\/j.bbamcr.2021.119141_bb0530","doi-asserted-by":"crossref","first-page":"34529","DOI":"10.1074\/jbc.M113.488478","article-title":"A disintegrin and metalloprotease (ADAM) 10 and ADAM17 are major sheddases of T cell immunoglobulin and mucin domain 3 (Tim-3)","volume":"288","author":"Moller-Hackbarth","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2021.119141_bb0535","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9673537","article-title":"Recent advances in ADAM17 research: a promising target for cancer and inflammation","volume":"2017","author":"Moss","year":"2017","journal-title":"Mediat. Inflamm."},{"issue":"14","key":"10.1016\/j.bbamcr.2021.119141_bb0540","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1073\/pnas.1017067108","article-title":"Cross-domain inhibition of TACE ectodomain","volume":"108","author":"Tape","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.bbamcr.2021.119141_bb0545","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/protein\/gzu010","article-title":"Development of a \u2018mouse and human cross-reactive\u2019 affinity-matured exosite inhibitory human antibody specific to TACE (ADAM17) for cancer immunotherapy","volume":"27","author":"Kwok","year":"2014","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.bbamcr.2021.119141_bb0550","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejps.2017.05.057","article-title":"Anti-tumor effects of a \u2018human & mouse cross-reactive\u2019 anti-ADAM17 antibody in a pancreatic cancer model in vivo","volume":"110","author":"Ye","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.bbamcr.2021.119141_bb0555","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1158\/1535-7163.MCT-14-1040","article-title":"A monoclonal antibody to ADAM17 inhibits tumor growth by inhibiting EGFR and non-EGFR-mediated pathways","volume":"14","author":"Rios-Doria","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbamcr.2021.119141_bb0560","doi-asserted-by":"crossref","first-page":"35598","DOI":"10.1038\/srep35598","article-title":"Harnessing the natural inhibitory domain to control TNFalpha Converting Enzyme (TACE) activity in vivo","volume":"6","author":"Wong","year":"2016","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.bbamcr.2021.119141_bb0565","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091218","article-title":"ADAM17: an emerging therapeutic target for lung cancer","volume":"11","author":"Saad","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.bbamcr.2021.119141_bb0570","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1073\/pnas.1520175113","article-title":"Cell-type-restricted anti-cytokine therapy: TNF inhibition from one pathogenic source","volume":"113","author":"Efimov","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"42","key":"10.1016\/j.bbamcr.2021.119141_bb0575","doi-asserted-by":"crossref","first-page":"44151","DOI":"10.18632\/oncotarget.6629","article-title":"Cytokine secretion and NK cell activity in human ADAM17 deficiency","volume":"6","author":"Tsukerman","year":"2015","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.bbamcr.2021.119141_bb0580","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.humpath.2015.02.010","article-title":"Loss of ADAM17 is associated with severe multiorgan dysfunction","volume":"46","author":"Bandsma","year":"2015","journal-title":"Hum. Pathol."},{"issue":"8","key":"10.1016\/j.bbamcr.2021.119141_bb0585","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.cell.2021.02.053","article-title":"Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system","volume":"184","author":"Yeung","year":"2021","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bbamcr.2021.119141_bb0590","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrd.2018.45","article-title":"Interleukin-6: designing specific therapeutics for a complex cytokine","volume":"17","author":"Garbers","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbamcr.2021.119141_bb0595","doi-asserted-by":"crossref","DOI":"10.1038\/s41575-021-00473-x","article-title":"New insights into the IL-6 family of cytokines: from pathophysiology to therapeutics in metabolic, liver, and gastrointestinal diseases","author":"Giraldez","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.bbamcr.2021.119141_bb0600","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2021.02.062","article-title":"Therapeutic IL-6 trans-signalling inhibition by olamkicept (sgp130Fc) in patients with active inflammatory bowel disease","volume":"160","author":"Schreiber","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbamcr.2021.119141_bb0605","doi-asserted-by":"crossref","first-page":"S041","DOI":"10.1093\/ecco-jcc\/jjab073.040","article-title":"Efficacy and safety of the IL-6 trans-signalling inhibitor olamkicept: a phase 2 randomized, placebo-controlled trial in moderately to severely active ulcerative colitis","volume":"15","author":"Chen","year":"2021","journal-title":"J. Crohns Colit."},{"issue":"5","key":"10.1016\/j.bbamcr.2021.119141_bb0610","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cytogfr.2015.07.004","article-title":"Interleukin-6: biology, signaling and strategies of blockade","volume":"26","author":"Schaper","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"issue":"11","key":"10.1016\/j.bbamcr.2021.119141_bb0615","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112748","article-title":"EGFR in cancer: signaling mechanisms, drugs, and acquired resistance","volume":"13","author":"Uribe","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.bbamcr.2021.119141_bb0620","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1038\/s41467-020-18701-4","article-title":"Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during clinical latency","volume":"11","author":"Werner-Klein","year":"2020","journal-title":"Nat. Commun."},{"issue":"43","key":"10.1016\/j.bbamcr.2021.119141_bb0625","doi-asserted-by":"crossref","first-page":"26059","DOI":"10.1074\/jbc.M115.649509","article-title":"Shedding of endogenous interleukin-6 receptor (IL-6R) is governed by a disintegrin and metalloproteinase (ADAM) proteases while a full-length IL-6R isoform localizes to circulating microvesicles","volume":"290","author":"Schumacher","year":"2015","journal-title":"J. Biol. Chem."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488921001956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488921001956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T19:59:19Z","timestamp":1759089559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488921001956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":125,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0167488921001956"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2021.119141","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ADAM17 orchestrates Interleukin-6, TNF\u03b1 and EGF-R signaling in inflammation and cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2021.119141","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119141"}}